Drummond, Michael; Pouvourville, Gerard; Jones, Elizabeth; … - In: PharmacoEconomics 32 (2014) 5, pp. 509-520
The two approaches produce very similar assessments of added value, but have different attributes in terms of cost, timeliness, transparency and political acceptability. How these considerations impact market access and prices is difficult to assess, because of the lack of transparency...